LRP4 (O75096) variants and mutations
LRP4 (also known as O75096) is a human protein-coding gene encoding a low-density lipoprotein receptor-related protein 4 protein. It coordinates Wnt-related developmental signaling and serves as the agrin coreceptor that activates MuSK at the neuromuscular junction. Biallelic or dominant pathogenic variants can cause syndactyly, Cenani-Lenz syndactyly syndrome, or congenital myasthenic syndrome depending on the mechanism. This analysis covers 2,287 LRP4 variants and mutations. Of these, 50% have computational variant effect predictions. Disease context includes Cenani-Lenz syndactyly syndrome, sclerosteosis 2, and Cenani-Lenz syndrome. Example LRP4 variants include R2K, R2S, and R3W.
Variant analysis overview
- Gene: LRP4
- Protein: O75096
- UniProt accession: O75096
- Organism: Homo sapiens
- Variants analyzed: 2287
- Variant scope: all variants
- Completed: 2026-08-22
Variant and mutation evidence
- Variant composition: 1,959 unspecified-consequence records; 26 frameshift variants; 1 stop lost; 221 missense variants; 1 in-frame deletions; 70 synonymous variants; 9 stop-gained variants; 2 substitution
- Prediction scores: 1,143 variants have prediction scores (50% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Cenani-Lenz syndactyly syndrome, sclerosteosis 2, Cenani-Lenz syndrome, congenital myasthenic syndrome 17, Congenital myasthenic syndromes, sclerosteosis, venous thromboembolism, postsynaptic congenital myasthenic syndrome, Postsynaptic congenital myasthenic syndromes, polydactyly, heart disorder, deep vein thrombosis.
Protein structure and variant hotspots
- Protein features: 1 transmembrane segments; 11 domains; 7 post-translational modification sites.
- Structural context: 468 variants have structural context.
- PTM context: 7 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable LRP4 variants
Examples include R2K, R2S, R3W, Q4L, Q4P, W5R, A7T, L8P. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- R2K (p.Arg2Lys), gnomAD rs1297553790
- R2S (p.Arg2Ser), TOPMed rs1941985745
- R3W (p.Arg3Trp), TOPMed rs1941985504
- Q4L (p.Gln4Leu), Ensembl rs1941985405
- Q4P (p.Gln4Pro), Ensembl rs1941985405
- W5R (p.Trp5Arg), 1000Genomes rs550380380
- A7T (p.Ala7Thr), ExAC rs774522355, gnomAD rs774522355
- L8P (p.Leu8Pro), TOPMed rs1941985152, gnomAD rs1941985152
- L10F (p.Leu10Phe), Ensembl rs867998595
- A12V (p.Ala12Val), ExAC rs771113574, TOPMed rs771113574, gnomAD rs771113574, Uncertain significance, Inborn genetic diseases
- L13V (p.Leu13Val), TOPMed rs1941984954
- L14F (p.Leu14Phe), TOPMed rs1448310579
- C15F (p.Cys15Phe), Ensembl rs1592559759
- H17Q (p.His17Gln), gnomAD rs1468417987, Uncertain significance
- G18D (p.Gly18Asp), 1000Genomes rs200914006, TOPMed rs200914006, Uncertain significance, Inborn genetic diseases
- A20G (p.Ala20Gly), 1000Genomes rs542378473, ExAC rs542378473, TOPMed rs542378473, gnomAD rs542378473, Uncertain significance, Congenital myasthenic syndrome 17; Cenani-Lenz syndactyly syndrome; Sclerosteosi
- A20S (p.Ala20Ser), TOPMed rs1941694672
- S22I (p.Ser22Ile), rs777229906, ClinGen CA5970611, ClinVar RCV000824197, ExAC rs777229906, AlphaMissense 0.11, MetaLR 0.44, Uncertain significance, Cenani-Lenz syndactyly syndrome; Sclerosteosis 2; Congenital myasthenic syndrome
- E24K (p.Glu24Lys), rs200465829, ClinGen CA5970608, ClinVar RCV001211955, ClinVar RCV002267083, AlphaMissense 0.13, MetaLR 0.45, Uncertain significance, not specified; not provided; Congenital myasthenic syndrome 17
- C25G (p.Cys25Gly), Ensembl rs1592549057
- G28D (p.Gly28Asp), rs1183268699, ClinGen CA380291330, ClinVar RCV001965012, ClinVar RCV003289270, AlphaMissense 0.28, MetaLR 0.80, Uncertain significance, Sclerosteosis 2; Congenital myasthenic syndrome 17; Cenani-Lenz syndactyly syndr
- R29Q (p.Arg29Gln), rs752084061, ClinGen CA5970606, NCI-TCGA Cosmic COSV1010, ClinVar RCV003091977, AlphaMissense 0.07, MetaLR 0.66, Uncertain significance, Cenani-Lenz syndactyly syndrome; Sclerosteosis 2; Congenital myasthenic syndrome
- R29W (p.Arg29Trp), ESP rs146259656, ExAC rs146259656, TOPMed rs146259656, gnomAD rs146259656, Uncertain significance, Inborn genetic diseases
- H31Q (p.His31Gln), Ensembl rs771825388
- H31R (p.His31Arg), Ensembl rs1941693880
- S37R (p.Ser37Arg), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A38V (p.Ala38Val), ExAC rs762929666, gnomAD rs762929666
- L39F (p.Leu39Phe), Ensembl rs2134870161
- G40* (p.Gly40Ter), Ensembl rs1024023349
- E41K (p.Glu41Lys), ExAC rs773501026, TOPMed rs773501026, gnomAD rs773501026
- E41Q (p.Glu41Gln), ExAC rs773501026, TOPMed rs773501026, gnomAD rs773501026
- I45V (p.Ile45Val), gnomAD rs1378468014
- A47D (p.Ala47Asp), gnomAD rs1314654325
- A47G (p.Ala47Gly), gnomAD rs1314654325
- A47V (p.Ala47Val), NCI-TCGA TCGA novel, Uncertain significance, Congenital myasthenic syndrome 17; Cenani-Lenz syndactyly syndrome; Sclerosteosi
- Q48P (p.Gln48Pro), TOPMed rs1309344878, gnomAD rs1309344878
- Q48R (p.Gln48Arg), rs1309344878, ClinGen CA380291119, ClinVar RCV003801571, AlphaMissense 0.12, MetaLR 0.82, Uncertain significance, Sclerosteosis 2; Cenani-Lenz syndactyly syndrome; Congenital myasthenic syndrome
- W49S (p.Trp49Ser), TOPMed rs1941692818, gnomAD rs1941692818
- D54E (p.Asp54Glu), rs745869587, NCI-TCGA Cosmic COSV6613, ClinGen CA5970598, ClinVar RCV002654252, AlphaMissense 0.81, MetaLR 0.72, Uncertain significance, Cenani-Lenz syndactyly syndrome; Congenital myasthenic syndrome 17; Sclerosteosi
- N55H (p.Asn55His), TOPMed rs1362943824, gnomAD rs1362943824
- N55S (p.Asn55Ser), ExAC rs774255246, gnomAD rs774255246
- C57R (p.Cys57Arg), Ensembl rs1941692381
- G58R (p.Gly58Arg), rs139901577, ESP rs139901577, TOPMed rs139901577, gnomAD rs139901577, AlphaMissense 0.62, MetaLR 0.85, Uncertain significance, Cenani-Lenz syndactyly syndrome; Sclerosteosis 2; Congenital myasthenic syndrome
- D59G (p.Asp59Gly), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- S61N (p.Ser61Asn), TOPMed rs889686024, gnomAD rs889686024
- D62N (p.Asp62Asn), rs1050038014, ClinGen CA221658202, ClinVar RCV003782150, ClinVar RCV005353285, AlphaMissense 0.99, MetaLR 0.98, Uncertain significance, Inborn genetic diseases; Cenani-Lenz syndactyly syndrome; Congenital myasthenic
- D64E (p.Asp64Glu), ExAC rs747813561, TOPMed rs747813561, gnomAD rs747813561
- D64N (p.Asp64Asn), gnomAD rs1186531891, Uncertain significance, Inborn genetic diseases
- D64V (p.Asp64Val), ExAC rs755671929, TOPMed rs755671929, gnomAD rs755671929
- G65A (p.Gly65Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- C66F (p.Cys66Phe), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L68I (p.Leu68Ile), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- T70A (p.Thr70Ala), ExAC rs772646348, gnomAD rs772646348
- S72F (p.Ser72Phe), gnomAD rs1299239483
- S72P (p.Ser72Pro), Ensembl rs1592547035
- P73L (p.Pro73Leu), TOPMed rs1941642308, Uncertain significance, not provided
- P73S (p.Pro73Ser), gnomAD rs1462100682
- L74I (p.Leu74Ile), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- F76V (p.Phe76Val), ExAC rs769317290, gnomAD rs769317290
- H77N (p.His77Asn), rs2539779284, ClinGen CA380290469, ClinVar RCV002761240, Uncertain significance, Cenani-Lenz syndactyly syndrome; Sclerosteosis 2; Congenital myasthenic syndrome
- H77R (p.His77Arg), rs780980400, ClinGen CA5970569, ClinVar RCV002913604, ClinVar RCV003167925, AlphaMissense 0.08, MetaLR 0.55, Uncertain significance, Sclerosteosis 2; Cenani-Lenz syndactyly syndrome; Congenital myasthenic syndrome
- D79E (p.Asp79Glu), 1000Genomes rs547765113, ExAC rs547765113, TOPMed rs547765113, gnomAD rs547765113
- N80D (p.Asn80Asp), ExAC rs747313271, gnomAD rs747313271, REVEL 0.44, CADD 19.60
- G81S (p.Gly81Ser), Ensembl rs1941641889
- C83F (p.Cys83Phe), rs1565801283, ClinGen CA380290366, ClinVar RCV000722908, Ensembl rs1565801283, AlphaMissense 1.00, MetaLR 1.00, Uncertain significance, not provided
- I84V (p.Ile84Val), TOPMed rs1941641625
- R85C (p.Arg85Cys), rs1219866663, NCI-TCGA Cosmic COSV1010, Ensembl rs1219866663, AlphaMissense 0.90, MetaLR 0.91, Variant assessed as somatic; moderate impact.
- R85H (p.Arg85His), TOPMed rs1011882566, gnomAD rs1011882566
- R86C (p.Arg86Cys), rs1466848737, ClinGen CA380290337, ClinVar RCV002975201, TOPMed rs1466848737, AlphaMissense 0.79, MetaLR 0.94, Uncertain significance, Cenani-Lenz syndactyly syndrome; Sclerosteosis 2; Congenital myasthenic syndrome
- R86H (p.Arg86His), rs138239756, ClinGen CA5970564, ClinVar RCV000643975, ClinVar RCV003129960, AlphaMissense 0.29, MetaLR 0.86, Conflicting interpretations, Congenital myasthenic syndrome 17; Sclerosteosis 2; Cenani-Lenz syndactyly syndr
- R86L (p.Arg86Leu), ESP rs138239756, ExAC rs138239756, TOPMed rs138239756, gnomAD rs138239756, Uncertain significance, Congenital myasthenic syndrome 17; Cenani-Lenz syndactyly syndrome; Sclerosteosi
- R86P (p.Arg86Pro), ESP rs138239756, ExAC rs138239756, TOPMed rs138239756, gnomAD rs138239756, Uncertain significance, not provided; Sclerosteosis 2; Cenani-Lenz syndactyly syndrome
- S87F (p.Ser87Phe), ESP rs376802865, ExAC rs376802865, TOPMed rs376802865, gnomAD rs376802865, Uncertain significance, Congenital myasthenic syndrome 17; Cenani-Lenz syndactyly syndrome; Sclerosteosi
- G92R (p.Gly92Arg), rs754071316, ClinGen CA380290275, ClinVar RCV002303599, ClinGen CA5970561, AlphaMissense 0.73, MetaLR 0.94, Uncertain significance, Sclerosteosis 2; Congenital myasthenic syndrome 17; Cenani-Lenz syndactyly syndr
- D93G (p.Asp93Gly), rs1231831456, ClinGen CA380290259, ClinVar RCV001756841, ClinVar RCV006377408, AlphaMissense 0.98, MetaLR 0.91, Uncertain significance, Inborn genetic diseases; not provided
- D93N (p.Asp93Asn), gnomAD rs1418475157
- N94I (p.Asn94Ile), ExAC rs759355938, TOPMed rs759355938, gnomAD rs759355938, Uncertain significance, Inborn genetic diseases
- N94K (p.Asn94Lys), 1000Genomes rs17848224, ESP rs17848224, ExAC rs17848224, TOPMed rs17848224, Likely benign
- N94S (p.Asn94Ser), ExAC rs759355938, TOPMed rs759355938, gnomAD rs759355938, Uncertain significance, Congenital myasthenic syndrome 17; Cenani-Lenz syndactyly syndrome; Sclerosteosi
- D95N (p.Asp95Asn), rs1431228331, gnomAD rs1431228331, REVEL 0.13, CADD 13.40, Variant assessed as somatic; moderate impact.
- E97A (p.Glu97Ala), rs766174802, ClinGen CA5970557, ClinVar RCV001107950, ClinVar RCV002556112, AlphaMissense 0.38, MetaLR 0.82, Uncertain significance, Cenani-Lenz syndactyly syndrome; Sclerosteosis 2; Congenital myasthenic syndrome
- E97V (p.Glu97Val), rs766174802, NCI-TCGA Cosmic COSV6613, ExAC rs766174802, TOPMed rs766174802, AlphaMissense 0.38, MetaLR 0.82, Uncertain significance, Congenital myasthenic syndrome 17; Cenani-Lenz syndactyly syndrome; Sclerosteosi
- D99H (p.Asp99His), Ensembl rs1941640298, Likely pathogenic, Congenital myasthenic syndrome 17; Cenani-Lenz syndactyly syndrome; Sclerosteosi
- S100L (p.Ser100Leu), rs762837686, ClinGen CA5970556, ClinVar RCV000531555, ClinVar RCV002526152, AlphaMissense 0.87, MetaLR 0.96, Uncertain significance, Inborn genetic diseases; Cenani-Lenz syndactyly syndrome; Sclerosteosis 2
- D101N (p.Asp101Asn), TOPMed rs1350368496, gnomAD rs1350368496
- E102K (p.Glu102Lys), ExAC rs769246087, gnomAD rs769246087, Uncertain significance, not provided
- Q103E (p.Gln103Glu), ExAC rs761350442, TOPMed rs761350442, gnomAD rs761350442, Uncertain significance, Inborn genetic diseases
- D104E (p.Asp104Glu), TOPMed rs1941639450
- D104N (p.Asp104Asn), rs2134865411, ClinGen CA380290095, ClinVar RCV002032264, Ensembl rs2134865411, AlphaMissense 0.10, MetaLR 0.69, Uncertain significance, Sclerosteosis 2; Cenani-Lenz syndactyly syndrome; Congenital myasthenic syndrome
- P106A (p.Pro106Ala), ExAC rs747402851, TOPMed rs747402851, gnomAD rs747402851
- P106H (p.Pro106His), NCI-TCGA TCGA novel, 1000Genomes rs556889686, ExAC rs556889686, TOPMed rs556889686, Uncertain significance, Inborn genetic diseases
- P106L (p.Pro106Leu), rs556889686, ClinGen CA5970533, ClinVar RCV001228404, ClinVar RCV002563700, AlphaMissense 0.12, MetaLR 0.65, Uncertain significance, Cenani-Lenz syndactyly syndrome; Congenital myasthenic syndrome 17; Sclerosteosi
- P106S (p.Pro106Ser), ExAC rs747402851, TOPMed rs747402851, gnomAD rs747402851
- P107H (p.Pro107His), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P107L (p.Pro107Leu), rs2134864767, ClinGen CA380290004, ClinVar RCV001893290, Ensembl rs2134864767, AlphaMissense 0.11, MetaLR 0.63, Uncertain significance, Sclerosteosis 2; Cenani-Lenz syndactyly syndrome; Congenital myasthenic syndrome
- R108G (p.Arg108Gly), ExAC rs775191643, TOPMed rs775191643, gnomAD rs775191643, Uncertain significance
- R108Q (p.Arg108Gln), rs772332690, ClinGen CA5970531, ClinVar RCV001368019, ExAC rs772332690, AlphaMissense 0.22, MetaLR 0.78, Uncertain significance, Cenani-Lenz syndactyly syndrome; Congenital myasthenic syndrome 17; Sclerosteosi
- R108W (p.Arg108Trp), rs775191643, ClinGen CA5970532, ClinVar RCV001220056, ExAC rs775191643, AlphaMissense 0.58, MetaLR 0.87, Uncertain significance, Sclerosteosis 2; Congenital myasthenic syndrome 17; Cenani-Lenz syndactyly syndr
- C110S (p.Cys110Ser), ExAC rs746174984, gnomAD rs746174984
- E111K (p.Glu111Lys), TOPMed rs1292022846
- E112K (p.Glu112Lys), gnomAD rs1171630290
- D113Y (p.Asp113Tyr), NCI-TCGA Cosmic COSV6613, Variant assessed as somatic; moderate impact.
- E114K (p.Glu114Lys), rs771377480, NCI-TCGA Cosmic COSV6613, ExAC rs771377480, gnomAD rs771377480, AlphaMissense 0.95, MetaLR 0.85, Variant assessed as somatic; moderate impact.
- Q118R (p.Gln118Arg), Ensembl rs1239213317
- N119H (p.Asn119His), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- N119I (p.Asn119Ile), rs2539778362, ClinGen CA380289899, ClinVar RCV002982604, Uncertain significance, Sclerosteosis 2; Congenital myasthenic syndrome 17; Cenani-Lenz syndactyly syndr
- G120D (p.Gly120Asp), ExAC rs749771283, gnomAD rs749771283, Uncertain significance, Congenital myasthenic syndrome 17; Cenani-Lenz syndactyly syndrome; Sclerosteosi
- G120S (p.Gly120Ser), NCI-TCGA Cosmic COSV6613, Variant assessed as somatic; moderate impact.
- Y121* (p.Tyr121Ter), ExAC rs777870713, gnomAD rs777870713
- R124L (p.Arg124Leu), NCI-TCGA Cosmic COSV1010, Variant assessed as somatic; moderate impact.
- R124Q (p.Arg124Gln), TOPMed rs1268069891, gnomAD rs1268069891
- R124W (p.Arg124Trp), TOPMed rs1941630511, gnomAD rs1941630511
- S125R (p.Ser125Arg), ExAC rs756180642, gnomAD rs756180642
- S125T (p.Ser125Thr), gnomAD rs1941630387
- C129W (p.Cys129Trp), 1000Genomes rs80333596, ESP rs80333596, ExAC rs80333596, TOPMed rs80333596, Benign
- C129Y (p.Cys129Tyr), gnomAD rs1941630109
- D130N (p.Asp130Asn), ExAC rs765113454, TOPMed rs765113454, gnomAD rs765113454, REVEL 0.07, CADD 11.10
- G131D (p.Gly131Asp), TOPMed rs1941629527
- G131S (p.Gly131Ser), gnomAD rs1323888185
- D132G (p.Asp132Gly), gnomAD rs1406894880
- N133D (p.Asn133Asp), ESP rs146894429, ExAC rs146894429, gnomAD rs146894429
- D134Y (p.Asp134Tyr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- D137N (p.Asp137Asn), rs267607222, ClinGen CA117685, ClinVar RCV000006041, ClinVar RCV002496277, AlphaMissense 0.94, MetaLR 0.96, Likely pathogenic, Sclerosteosis 2; Cenani-Lenz syndactyly syndrome; Congenital myasthenic syndrome
- D140G (p.Asp140Gly), TOPMed rs1490002157, gnomAD rs1490002157
- D140N (p.Asp140Asn), rs781681900, NCI-TCGA Cosmic COSV6613, ExAC rs781681900, gnomAD rs781681900, AlphaMissense 1.00, MetaLR 0.99, Variant assessed as somatic; moderate impact.
- D140Y (p.Asp140Tyr), ExAC rs781681900, gnomAD rs781681900
- Q142K (p.Gln142Lys), gnomAD rs1246644250, Uncertain significance, Inborn genetic diseases
- Q142R (p.Gln142Arg), gnomAD rs1222707563
- M145T (p.Met145Thr), gnomAD rs1406427577
- R146C (p.Arg146Cys), NCI-TCGA Cosmic COSV6613, Ensembl rs1565800589, Uncertain significance, Congenital myasthenic syndrome 17; Cenani-Lenz syndactyly syndrome; Sclerosteosi
- R146H (p.Arg146His), TOPMed rs1178347520, gnomAD rs1178347520
- R146S (p.Arg146Ser), Ensembl rs1565800589, Uncertain significance
- K147E (p.Lys147Glu), rs893448826, []
- S149F (p.Ser149Phe), rs1239578585, ClinGen CA380289668, ClinVar RCV001208727, TOPMed rs1239578585, AlphaMissense 0.83, MetaLR 0.91, Uncertain significance, Cenani-Lenz syndactyly syndrome; Sclerosteosis 2; Congenital myasthenic syndrome
- D150N (p.Asp150Asn), rs200746048, ClinGen CA5970489, ClinVar RCV001338645, 1000Genomes rs200746048, AlphaMissense 0.11, MetaLR 0.70, Uncertain significance, Congenital myasthenic syndrome 17; Sclerosteosis 2; Cenani-Lenz syndactyly syndr
- F153L (p.Phe153Leu), TOPMed rs1163449749
- R154C (p.Arg154Cys), rs1941619145, ClinGen CA380289634, ClinVar RCV002738121, NCI-TCGA TCGA novel, AlphaMissense 0.57, MetaLR 0.94, Uncertain significance, Inborn genetic diseases
- R154H (p.Arg154His), rs748199837, ClinGen CA5970487, ClinVar RCV001965122, ExAC rs748199837, AlphaMissense 0.11, MetaLR 0.88, Uncertain significance, Sclerosteosis 2; Congenital myasthenic syndrome 17; Cenani-Lenz syndactyly syndr
- R154L (p.Arg154Leu), ExAC rs748199837, TOPMed rs748199837, gnomAD rs748199837, Uncertain significance
- S156G (p.Ser156Gly), gnomAD rs1285239491
- G158R (p.Gly158Arg), rs193247849, ClinGen CA5970485, ClinVar RCV001972158, 1000Genomes rs193247849, AlphaMissense 0.80, MetaLR 0.93, Uncertain significance, not provided
- C160Y (p.Cys160Tyr), rs267607221, ClinGen CA117686, ClinVar RCV000006044, UniProt VAR 063777, AlphaMissense 1.00, MetaLR 1.00, Pathogenic, Cenani-Lenz syndactyly syndrome
- I161F (p.Ile161Phe), ExAC rs780414123, gnomAD rs780414123, Uncertain significance, Inborn genetic diseases
- I161L (p.Ile161Leu), ExAC rs780414123, gnomAD rs780414123, Uncertain significance
- E163D (p.Glu163Asp), rs1941618309, ClinGen CA380289569, ClinVar RCV001974320, Ensembl rs1941618309, AlphaMissense 0.28, MetaLR 0.67, Uncertain significance, Cenani-Lenz syndactyly syndrome; Sclerosteosis 2; Congenital myasthenic syndrome
- E163G (p.Glu163Gly), NCI-TCGA Cosmic COSV1010, Variant assessed as somatic; moderate impact.
- E163K (p.Glu163Lys), NCI-TCGA Cosmic COSV1010, Variant assessed as somatic; moderate impact.
- H164P (p.His164Pro), TOPMed rs1303429562, gnomAD rs1303429562
- W165* (p.Trp165Ter), TOPMed rs1941618052, gnomAD rs1941618052
- Y166C (p.Tyr166Cys), TOPMed rs202200592, gnomAD rs202200592
- Y166N (p.Tyr166Asn), TOPMed rs897915373
- D168N (p.Asp168Asn), TOPMed rs1941617715, gnomAD rs1941617715
- G169D (p.Gly169Asp), gnomAD rs1420880652
- G169S (p.Gly169Ser), rs201585639, ClinGen CA5970480, ClinVar RCV000643977, ClinVar RCV004737923, AlphaMissense 0.19, MetaLR 0.92, Uncertain significance, Sclerosteosis 2; Cenani-Lenz syndactyly syndrome; Congenital myasthenic syndrome
- T171I (p.Thr171Ile), TOPMed rs1382538434, gnomAD rs1382538434, Uncertain significance, Inborn genetic diseases
- D172H (p.Asp172His), ExAC rs780819863, gnomAD rs780819863, Uncertain significance
- D172N (p.Asp172Asn), rs780819863, ClinGen CA5970478, NCI-TCGA Cosmic COSV6613, ClinVar RCV002008563, AlphaMissense 1.00, MetaLR 0.98, Uncertain significance, Sclerosteosis 2; Congenital myasthenic syndrome 17; Cenani-Lenz syndactyly syndr
- K174Q (p.Lys174Gln), Ensembl rs1941616983
- K174R (p.Lys174Arg), TOPMed rs1941616899
- D175E (p.Asp175Glu), rs757433016, ClinGen CA221654895, ClinVar RCV003089294, Ensembl rs757433016, AlphaMissense 0.97, MetaLR 0.94, Uncertain significance, Congenital myasthenic syndrome 17; Cenani-Lenz syndactyly syndrome; Sclerosteosi
- G176A (p.Gly176Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G176S (p.Gly176Ser), gnomAD rs1185458127
- S177Y (p.Ser177Tyr), rs1565800416, ClinGen CA380289471, ClinVar RCV000723205, Ensembl rs1565800416, AlphaMissense 0.76, MetaLR 0.97, Uncertain significance, not provided
- D178E (p.Asp178Glu), ExAC rs765950285, gnomAD rs765950285
- D178Y (p.Asp178Tyr), NCI-TCGA Cosmic COSV1010, TOPMed rs1941616434, gnomAD rs1941616434, Variant assessed as somatic; moderate impact.
- E180D (p.Glu180Asp), NCI-TCGA Cosmic COSV6613, Variant assessed as somatic; moderate impact.
- E180G (p.Glu180Gly), rs201957426, ClinGen CA5970472, ClinVar RCV000643983, ClinVar RCV001107295, AlphaMissense 0.12, MetaLR 0.79, Conflicting interpretations, Congenital myasthenic syndrome 17; Cenani-Lenz syndactyly syndrome; Sclerosteosi
- E180K (p.Glu180Lys), ExAC rs763340602, gnomAD rs763340602
- E180Q (p.Glu180Gln), ExAC rs763340602, gnomAD rs763340602, Uncertain significance, not provided
- N181D (p.Asn181Asp), rs1208569811, ClinGen CA380289445, ClinVar RCV001243289, TOPMed rs1208569811, AlphaMissense 0.09, MetaLR 0.63, Uncertain significance, Congenital myasthenic syndrome 17; Cenani-Lenz syndactyly syndrome; Sclerosteosi
- N181K (p.Asn181Lys), Ensembl rs1941615965
- C182=, NCI-TCGA Cosmic COSV1010, Variant assessed as somatic; low impact.
- P183S (p.Pro183Ser), rs765567296, ClinGen CA5970471, ClinVar RCV001988321, ExAC rs765567296, AlphaMissense 0.07, MetaLR 0.69, Uncertain significance, Sclerosteosis 2; Cenani-Lenz syndactyly syndrome; Congenital myasthenic syndrome
- A185V (p.Ala185Val), rs764463798, ClinGen CA5970451, ClinVar RCV003188973, ExAC rs764463798, AlphaMissense 0.07, MetaLR 0.36, Uncertain significance, Inborn genetic diseases
- V186G (p.Val186Gly), ExAC rs760856907, gnomAD rs760856907
- P187L (p.Pro187Leu), rs2134862345, ClinGen CA380289394, ClinVar RCV002295507, Ensembl rs2134862345, AlphaMissense 0.07, MetaLR 0.61, Uncertain significance, Sclerosteosis 2; Congenital myasthenic syndrome 17; Cenani-Lenz syndactyly syndr
- P187S (p.Pro187Ser), NCI-TCGA Cosmic COSV6613, Variant assessed as somatic; moderate impact.
- A188T (p.Ala188Thr), gnomAD rs1463730442
- A188V (p.Ala188Val), rs772245536, ClinGen CA5970448, ClinVar RCV000503043, ClinVar RCV001037702, AlphaMissense 0.07, MetaLR 0.45, Uncertain significance, Congenital myasthenic syndrome 17; Cenani-Lenz syndactyly syndrome; Sclerosteosi
- P189L (p.Pro189Leu), gnomAD rs1466750237
Public LRP4 analysis runs
- LRP4 analysis run — LRP4 (2,287 variants) — completed 2026-08-22